<?xml version="1.0" encoding="UTF-8"?>
<p class="p">Macrophages, as innate immune cells, initiate inflammation and immune response [
 <xref rid="B16-molecules-23-01857" ref-type="bibr" class="xref">16</xref>]. LPS is the main component of endotoxin and is formed by a phosphoglycolipid or lipid A that is covalently linked to a hydrophilic heteropolysaccharide [
 <xref rid="B17-molecules-23-01857" ref-type="bibr" class="xref">17</xref>]. When challenged with LPS, macrophages are activated and release various pro-inflammatory factors, such as IL-1β, IL-6, and TNF-α [
 <xref rid="B18-molecules-23-01857" ref-type="bibr" class="xref">18</xref>]. The macrophage is activated as a defense mechanism, and is generally beneficial [
 <xref rid="B19-molecules-23-01857" ref-type="bibr" class="xref">19</xref>]. However, if the inflammation is uncontrolled, the excessive release may result in extensive tissue damage and pathological changes [
 <xref rid="B20-molecules-23-01857" ref-type="bibr" class="xref">20</xref>]. OEO exerts a significant anti-inflammatory effect in vitro and in vivo [
 <xref rid="B12-molecules-23-01857" ref-type="bibr" class="xref">12</xref>,
 <xref rid="B21-molecules-23-01857" ref-type="bibr" class="xref">21</xref>]. Our previous study found that OEO decreases the pro-inflammatory expression in pig models [
 <xref rid="B21-molecules-23-01857" ref-type="bibr" class="xref">21</xref>]. However, the molecular mechanisms by which OEO improves the anti-inflammation status are unknown. 
</p>
